Mellicell
UEI: EFGLLLKFX2S7
• CAGE: 8N0Q3
Overview
Awardee Type
Parent
Company Description
MelliCell is a drug discovery startup devoted to finding type 2 diabetes medicine. Utilizing our adipocyte culturing technology, we hope to find therapeutics that will help treat obesity at its roots.
Name
Mellicell
Website
Headquarters
Newton, MA
United States
United States
Most Recent Award
May 9, 2024
Calculating
Federal grant recipient
MELLICELL INC
(UEI EFGLLLKFX2S7, CAGE 8N0Q3)
is headquartered in Newton MA.
The corporation
was founded in June 2020 and
federally registered in
June 2020.
Federal Award Analysis
Mellicell federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
MELLICELL INC
UEI
EFGLLLKFX2S7
CAGE Code
8N0Q3
Primary NAICS
None Reported
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Assistance Awards
Date Founded
June 17, 2020
Initial Registration
June 29, 2020
Last Registration
Dec. 10, 2024
Registration Activation
Dec. 6, 2024
Registration Expiration
Dec. 4, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
Not Available
Reported NAICS
None Reported
Accepts Credit Cards
No